These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 14510626)

  • 1. Treatment of childhood asthma: how do the available options compare?
    Coghlan D; Powell C
    Paediatr Drugs; 2003; 5(10):685-98. PubMed ID: 14510626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B; Faulds D
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological strategies for self-management of asthma exacerbations.
    Reddel HK; Barnes DJ;
    Eur Respir J; 2006 Jul; 28(1):182-99. PubMed ID: 16816348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS
    Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
    Motala C; Kling S; Gie R; Potter PC; Manjra A; Vermeulen J; Weinberg EG; Green R
    S Afr Med J; 2000 May; 90(5 Pt 2):524-8, 530, 532 passim. PubMed ID: 10901828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M; Richards DH; Beghé B; Fabbri L
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
    Reynolds NA; Lyseng-Williamson KA; Wiseman LR
    Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.